Healthcare provider profile · identity verified

Kevin Lee Jackson, MD

Allopathic & Osteopathic Physicians|Internal Medicine · OPELIKA, AL · NPI 1316938517

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Kevin Lee Jackson, MD received $122.95 in general payments during 2025 across 6 reported records.

Exact Sciences Corporation accounted for 20.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 6 associated products.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Creon by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 48 claims for Synthroid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$122.95

6 reported records · 6 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$24.75	20.1%	1	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$24.69	20.1%	1	2025
Inspire Medical Systems, Inc.	Unresolved — no canonical attribution shown	$23.15	18.8%	1	2025
Boston Scientific Corporation	Unresolved — no canonical attribution shown	$22.19	18.1%	1	2025
Kowa Pharmaceuticals America, Inc.	Unresolved — no canonical attribution shown	$14.23	11.6%	1	2025
Metacel Pharmaceuticals LLC	Unresolved — no canonical attribution shown	$13.94	11.3%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$122.95	6

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$24.75	1	2025
Source payment records 2025-03-18 · Exact Sciences Corporation · $24.75 · Open Payments source
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$24.69	1	2025
Source payment records 2025-09-17 · ABBVIE INC. · $24.69 · Open Payments source
INSPIRE Normalized: inspire	Device	Inspire Medical Systems, Inc.	$23.15	1	2025
Source payment records 2025-02-07 · Inspire Medical Systems, Inc. · $23.15 · Open Payments source
WATCHMAN Access System Normalized: watchman access system	Device	Boston Scientific Corporation	$22.19	1	2025
Source payment records 2025-02-24 · Boston Scientific Corporation · $22.19 · Open Payments source
ZORYVE Normalized: zoryve	Drug	Kowa Pharmaceuticals America, Inc.	$14.23	1	2025
Source payment records 2025-07-15 · Kowa Pharmaceuticals America, Inc. · $14.23 · Open Payments source
OZOBAX Normalized: ozobax	Drug	Metacel Pharmaceuticals LLC	$13.94	1	2025
Source payment records 2025-01-28 · Metacel Pharmaceuticals LLC · $13.94 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	CREON open payments reported associated product	CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608	Creon · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	30	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	48	15

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	952	278
Atorvastatin Calcium	Atorvastatin Calcium	945	256
Levothyroxine Sodium	Levothyroxine Sodium	835	198
Amlodipine Besylate	Amlodipine Besylate	705	195
Pantoprazole Sodium	Pantoprazole Sodium	686	194
Gabapentin	Gabapentin	594	140
Rosuvastatin Calcium	Rosuvastatin Calcium	520	173
Omeprazole	Omeprazole	441	124
Tramadol Hcl	Tramadol Hcl	366	72
Meloxicam	Meloxicam	364	127
Metoprolol Succinate	Metoprolol Succinate	340	105
Alprazolam	Alprazolam	328	48
Carvedilol	Carvedilol	321	84
Trazodone Hcl	Trazodone Hcl	321	76
Metformin Hcl	Metformin Hcl	319	95
Simvastatin	Simvastatin	294	80
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	285	70
Hydrochlorothiazide	Hydrochlorothiazide	261	73
Diazepam	Diazepam	247	56
Famotidine	Famotidine	240	68
Furosemide	Furosemide	223	59
Sertraline Hcl	Sertraline Hcl	217	64
Potassium Chloride	Potassium Chloride	214	61
Eliquis	Apixaban	198	41
Tamsulosin Hcl	Tamsulosin Hcl	197	54
Mounjaro	Tirzepatide	190	30
Zolpidem Tartrate	Zolpidem Tartrate	180	32
Fluticasone Propionate	Fluticasone Propionate	173	52
Pravastatin Sodium	Pravastatin Sodium	167	50
Doxycycline Hyclate	Doxycycline Hyclate	162	123
Ozempic	Semaglutide	162	26
Albuterol Sulfate Hfa	Albuterol Sulfate	158	56
Clopidogrel	Clopidogrel Bisulfate	154	42
Duloxetine Hcl	Duloxetine Hcl	152	45
Lorazepam	Lorazepam	148	31
Prednisone	Prednisone	146	108
Baclofen	Baclofen	139	36
Lisinopril	Lisinopril	137	43
Cephalexin	Cephalexin	130	101
Donepezil Hcl	Donepezil Hcl	129	35
Atenolol	Atenolol	127	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	125	27
Allopurinol	Allopurinol	121	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	119	34
Levofloxacin	Levofloxacin	111	85
Clonazepam	Clonazepam	110	21
Metoprolol Tartrate	Metoprolol Tartrate	106	32
Mirtazapine	Mirtazapine	105	31
Hydralazine Hcl	Hydralazine Hcl	104	29
Jardiance	Empagliflozin	104	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	98	69
Myrbetriq	Mirabegron	98	20
Enalapril Maleate	Enalapril Maleate	95	28
Diclofenac Sodium	Diclofenac Sodium	92	27
Esomeprazole Magnesium	Esomeprazole Magnesium	92	20
Montelukast Sodium	Montelukast Sodium	92	24
Tizanidine Hcl	Tizanidine Hcl	90	34
Mupirocin	Mupirocin	89	46
Buspirone Hcl	Buspirone Hcl	88	18
Citalopram Hbr	Citalopram Hydrobromide	86	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	83	21
Nifedipine Er	Nifedipine	80	21
Quetiapine Fumarate	Quetiapine Fumarate	77	13
Amitriptyline Hcl	Amitriptyline Hcl	75	18
Pregabalin	Pregabalin	74	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	74	13
Escitalopram Oxalate	Escitalopram Oxalate	70	22
Cefuroxime	Cefuroxime Axetil	68	58
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	68	45
Bupropion Xl	Bupropion Hcl	66	19
Fluconazole	Fluconazole	65	43
Ezetimibe	Ezetimibe	64	22
Glimepiride	Glimepiride	64	19
Valsartan	Valsartan	64	20
Methylprednisolone	Methylprednisolone	62	49
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	60	18
Dropsafe Prep Pads	Alcohol Antiseptic Pads	58	17
Fenofibrate	Fenofibrate,micronized	58	15
Paxlovid	Nirmatrelvir/Ritonavir	57	56
Benazepril Hcl	Benazepril Hcl	56	17
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	56	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	55	suppressed
Fenofibrate	Fenofibrate	55	15
Farxiga	Dapagliflozin Propanediol	54	17
Ondansetron Odt	Ondansetron	54	28
Hydrocortisone	Hydrocortisone	53	27
Metformin Hcl Er	Metformin Hcl	53	14
Januvia	Sitagliptin Phosphate	52	11
Temazepam	Temazepam	52	suppressed
Valacyclovir	Valacyclovir Hcl	52	17
Memantine Hcl	Memantine Hcl	51	13
Pentoxifylline	Pentoxifylline	49	17
Celecoxib	Celecoxib	48	17
Synthroid	Levothyroxine Sodium	48	15
Methocarbamol	Methocarbamol	47	11
Acyclovir	Acyclovir	45	suppressed
Finasteride	Finasteride	44	11
Ibuprofen	Ibuprofen	44	11
Novolog Flexpen	Insulin Aspart	43	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	43	13
Warfarin Sodium	Warfarin Sodium	43	suppressed
Nebivolol Hcl	Nebivolol Hcl	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	11
Sucralfate	Sucralfate	41	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	40	suppressed
Gemtesa	Vibegron	39	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	38	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	38	suppressed
Icosapent Ethyl	Icosapent Ethyl	36	suppressed
Propranolol Hcl	Propranolol Hcl	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Ciclopirox	Ciclopirox	31	11
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Azithromycin	Azithromycin	30	19
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	11
Lactulose	Lactulose	30	14
Linzess	Linaclotide	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Aripiprazole	Aripiprazole	29	suppressed
Bumetanide	Bumetanide	29	12
Chlorthalidone	Chlorthalidone	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	29	suppressed
Repatha Sureclick	Evolocumab	29	suppressed
Spironolactone	Spironolactone	29	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Azelastine Hcl	Azelastine Hcl	28	13
Morphine Sulfate Er	Morphine Sulfate	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Ramipril	Ramipril	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Morphine Sulfate	Morphine Sulfate	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	24	suppressed
Torsemide	Torsemide	24	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	24	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Estradiol	Estradiol	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	21	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	21	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Naproxen	Naproxen	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Dexlansoprazole Dr	Dexlansoprazole	19	suppressed
Diclofenac Potassium	Diclofenac Potassium	19	suppressed
Fentanyl	Fentanyl	19	suppressed
Amoxicillin	Amoxicillin	18	13
Bupropion Hcl	Bupropion Hcl	18	suppressed
Cefdinir	Cefdinir	18	17
Cholestyramine Light	Cholestyramine	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Colchicine	Colchicine	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Insulin Aspart Flexpen	Insulin Aspart	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	14
Alendronate Sodium	Alendronate Sodium	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	11
Loperamide	Loperamide Hcl	16	suppressed
Nadolol	Nadolol	16	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	16	suppressed
Klor-Con 10	Potassium Chloride	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	15	14
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Nystatin	Nystatin	14	13
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	13	suppressed
Cevimeline Hcl	Cevimeline Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Metronidazole	Metronidazole	13	13
Minoxidil	Minoxidil	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	13	suppressed
Acebutolol Hcl	Acebutolol Hcl	12	suppressed
Budesonide Dr	Budesonide	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Trulance	Plecanatide	12	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Primidone	Primidone	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$122.95 · 6 records	Exact Sciences Corporation	Cologuard Collection Kit, INSPIRE, OZOBAX, UBRELVY, WATCHMAN Access System, ZORYVE	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error